ArticleJournal of pharmaceutical health care and sciences2024

A case of successful contribution of therapeutic drug monitoring of valganciclovir as the prophylaxis against cytomegalovirus infection in a lung transplant recipient.

Yoshiki Katada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.